Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis - PubMed (original) (raw)

Comparative Study

Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis

Jieli Chen et al. Brain Res. 2004.

Abstract

We tested the hypothesis that intravenous infusion of human marrow stromal cells (hMSC) with a nitric oxide donor, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl) aminio] diazen-1-ium-1,2-diolate (DETA/NONOate), enhances angiogenesis, neurogenesis and neurological functional recovery after stroke in rats compared to individual therapy. Experimental groups consist of rats subjected to 2 h of middle cerebral artery occlusion (MCAo) and at 24 h after MCAo intravenous injection of (n=10/group): Group 1: phosphate buffered saline (PBS 1 ml) for control. Group 2: NONOate alone (0.4 mg/kg). Group 3: hMSCs (1 x 10(6)) alone. Group 4: hMSCs (1 x 10(6)) with NONOate (0.4 mg/kg). Functional tests and immunohistochemical staining were performed. Marginal functional recovery after treatment of stroke was found with 1 x 10(6) hMSCs alone (p=0.06) and no benefit was detected with NONOate alone (0.4 mg/kg, p=0.64). However, NONOate+hMSCs in combination significantly induced functional recovery (p<0.05). Treatment using hMSC in combination with NONOate significantly increased vessel perimeter and endothelial cell proliferation compared with hMSC or NONOate alone treatment (p<0.05). Cell proliferation and neurogenesis were assessed with bromodeoxyuridine (BrdU) labeling and immunostaining for cell type-specific markers. Combination treatment promoted increased, BrdU positive cell number in the subventricular zone (SVZ), migrating neuronal doublecortin immunoreactive cells and VEGF and bFGF expression in the ischemic boundary area compared to individual treatment. The functional therapeutic enhancement of combination treatment may be attributed to increased plasticity induced by the combination of a nitric oxide donor and hMSC therapy. These data suggest that pharmacological and cellular therapy may provide an additive therapeutic benefit after stroke.

PubMed Disclaimer

Cited by

Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats.
Xiong Y, Zhang Y, Mahmood A, Meng Y, Zhang ZG, Morris DC, Chopp M. Xiong Y, et al. J Neurosurg. 2012 May;116(5):1081-92. doi: 10.3171/2012.1.JNS111729. Epub 2012 Feb 10. J Neurosurg. 2012. PMID: 22324420 Free PMC article.
Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.
Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV. Yasuhara T, et al. J Neurosci. 2006 Nov 29;26(48):12497-511. doi: 10.1523/JNEUROSCI.3719-06.2006. J Neurosci. 2006. PMID: 17135412 Free PMC article.
Estradiol augments peri-infarct cerebral vascular density in experimental stroke.
Ardelt AA, Anjum N, Rajneesh KF, Kulesza P, Koehler RC. Ardelt AA, et al. Exp Neurol. 2007 Jul;206(1):95-100. doi: 10.1016/j.expneurol.2007.04.002. Epub 2007 Apr 18. Exp Neurol. 2007. PMID: 17509567 Free PMC article.
Systemic delivery of umbilical cord blood cells for stroke therapy: a review.
Yu G, Borlongan CV, Stahl CE, Hess DC, Ou Y, Kaneko Y, Yu SJ, Yang T, Fang L, Xie X. Yu G, et al. Restor Neurol Neurosci. 2009;27(1):41-54. doi: 10.3233/RNN-2009-0460. Restor Neurol Neurosci. 2009. PMID: 19164852 Free PMC article. Review.
Safety and Efficacy of Bone Marrow Mesenchymal Stem Cells in the Treatment of Ischemic Stroke: A Meta-Analysis.
Zhang F, Wang Y. Zhang F, et al. Ann Indian Acad Neurol. 2024 Mar-Apr;27(2):131-139. doi: 10.4103/aian.aian_736_23. Epub 2024 Apr 5. Ann Indian Acad Neurol. 2024. PMID: 38751928 Free PMC article.

Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis - PubMed (original) (raw)